SoftMaxx AI sells no peptides and takes no vendor money.
Human, small or uncontrolled Topical GHK-Cu has only a few small human studies: a 2026 review lists a 13-person post-laser study that was negative on objective measures and an 18-person eyebrow study, and calls the clinical evidence sparse, while a 2025 review notes a 'surprising absence of clinical studies'. For injected GHK-Cu, FDA says there are limited data in humans, and it flags a risk of immune reactions.[1][2][3]
Side by side
| On the skin (topical) | Injected | |
|---|---|---|
| Efficacy in people | A few small studies; reviewers call the evidence thin [4] [1] | We found no human efficacy study of injected GHK-Cu |
| Human safety data | Small studies; we found no problems reported | Limited, per FDA [3] |
| Gets where it is meant to go? | Lab results differ: one review calls skin permeation limited [5], another relatively good [2] | We found no human data |
| FDA status | Used in cosmetic anti-wrinkle products [2]; non-injectable forms are in compounding Category 1, "Under Evaluation" | We found no FDA-approved product in Drugs@FDA [6]; FDA lists it as nominated but withdrawn from Category 2 [3], and it is in none of the 503A categories [7] |
| Health Canada | We found no product in the Drug Product Database [8] | Named in a 2026 warning on peptides bought online [9] |
The two are different products with different evidence. Results for one do not carry over to the other.
- Expert review A 2026 systematic review calls the human literature on GHK-Cu thin and fragmented, a second 2026 review calls the clinical evidence sparse, and a 2025 review notes a surprising absence of clinical studies.[4][1][2]
- Regulator document We found no published human trial of injected GHK-Cu; FDA says there are limited data in humans.[3]
Injected GHK-Cu: limited human data
We found no published human trial of injected GHK-Cu, and FDA says there are limited data in humans [3]. We found no human dose that has been studied, so this page lists none.
A 2026 systematic review says microneedle delivery of GHK-Cu has yet to be evaluated in a registered, adequately powered human randomized trial published in the peer-reviewed literature [4]. Blends that include GHK-Cu, as sellers describe them, are covered on the GLOW and KLOW pages.
- In vitro (cells) A 2026 systematic review reports that microneedles greatly raised GHK-Cu uptake in lab and pig-skin models, and that this route has yet to be evaluated in a registered, adequately powered human randomized trial published in the peer-reviewed literature.[4]
- Expert review Reviews describe gray-market injectable peptides as having uncertain identity, purity, potency and sterility, with risks of contamination and inaccurate dosing.[10][11]
- Regulator document Health Canada warns that unauthorized injectable peptides, GHK-Cu among those it has seized, can lead to infections.[9]
What FDA and Health Canada say
FDA had listed injectable GHK-Cu in compounding Category 2, its significant-safety-risk list [3]. It left because the nominators withdrew, not because FDA cleared it; FDA's page listing it as withdrawn is dated 2026-04-22 [3], and injectable GHK-Cu appears in none of FDA's 503A category lists updated 2026-05-14 [7].
Non-injectable GHK-Cu is different: it is in Category 1, "Bulk Drug Substances Under Evaluation" [7]. FDA says it intends to consult its compounding advisory committee before the end of February 2027 on adding GHK-Cu to the 503A bulks list; the nomination still on file covers non-injectable routes [7].
- Regulator document FDA's compounding safety page cites possible immune reactions and limited human data for injectable GHK-Cu.[3]
- Regulator document FDA's nominations list records GHK-Cu's compounding categories by route.[7]
- Regulator document Health Canada warned in April 2026 against injecting peptides bought online, naming unauthorized products.[9]
The "injecting works better" myth
We found no trial showing that injecting is stronger. FDA says human data on injected GHK-Cu are limited [3], and we found no FDA-approved GHK-Cu product in Drugs@FDA [6].
We also found no human data on injected GHK-Cu in pregnancy, or for people with copper-handling disorders.
- Common belief
Injecting GHK-Cu works better than putting it on skin
No supporting study We found no published human trial of injected GHK-Cu. FDA flags a risk of immune reactions and says human data are limited.[3]
Topical GHK-Cu: small studies, real limits
On the skin, GHK-Cu is widely used in anti-wrinkle cosmetic products, and a 2025 review that calls it an anti-wrinkle ingredient on the strength of cellular studies also notes a surprising absence of clinical studies [2].
The main question is delivery. GHK-Cu is water-loving, and one review calls its permeation through the skin's outer layer limited [5], while a lab test found copper from it crossing excised skin [12].
- Animal GHK-Cu raised collagen in cultured fibroblasts and in rat wound chambers.[13][14]
- In vitro (cells) In a lab test on excised human skin, copper from GHK-Cu crossed the skin under an unlimited-dose setup; the authors called the amount potentially effective for inflammatory disease.[12]
- Case report A published human case report used GHK-Cu with four other actives and a device, so the effect cannot be isolated.[15]
- Regulator document FDA explains that the law defines drugs, in part, by their intended use, including "articles (other than food) intended to affect the structure or any function of the body of man or other animals". Some products meet the definitions of both cosmetics and drugs; FDA says intended use may be established in a number of ways, including claims stated on the product labeling.[16]
If you use a topical
If you try a copper-peptide serum, add one product at a time, so you can tell what your skin is reacting to. See what the trials measured.
Doses used in studies (not a recommendation)
Each row comes from the cited source: a study dose, a safety-review limit or a registered trial's planned dose, as labelled. Where the abstract states no amount, the row says so. They are a record of what was reported, not dosing instructions, and nothing here says what you should take.
| Studied in | Route | Amount reported | How often | How long | n | Source |
|---|---|---|---|---|---|---|
| human | topical, with a microdroplet resurfacing device | not reported (multi-ingredient solution) Study dose | once weekly | 12 weeks | 1 | [15] Case report, one 59-year-old man. |
Side effects and risks
- Regulator document Injected: possible immune reactions from aggregation and peptide-related impurities (flagged by FDA)[3]
- Expert review Injected gray-market products: uncertain identity, purity and sterility (reviews)[11][10]
- Regulator document Unauthorized injectable peptides, GHK-Cu among them: Health Canada warns of infections, allergic reactions and other serious complications[9]
- Case report Topical, with four other actives and a device: no adverse effects in a published case report[15]
Regulatory status (checked 2026-10-01 to 2026-10-03)
- United States (FDA)We found no FDA-approved product containing GHK-Cu in Drugs@FDA (searched 2026-10-01). (FDA:
Drugs@FDA search: ghk-cu — no approved product found
, captured 2026-10-01) FDA lists GHK-Cu (except for injectable routes of administration) in 503A Category 1, “Bulk Drug Substances Under Evaluation” (list updated 2026-05-14). (FDA:Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act
, captured 2026-10-03) - CanadaWe found no product containing GHK-Cu in Health Canada’s Drug Product Database (searched 2026-10-01). (Health Canada:
Health Canada Drug Product Database search: ghk-cu — no product found
, captured 2026-10-01) Health Canada named GHK-Cu in “Think twice before injecting peptides bought online: unauthorized products can seriously harm you”. (Health Canada:Think twice before injecting peptides bought online: unauthorized products can seriously harm you
, captured 2026-10-03) Health Canada named GHK-Cu in an advisory on unauthorized injectable peptide drugs seized from a seller (page last updated 2025-08-01). (Health Canada advisory: unauthorized injectable peptide drugs seized (2025), captured 2026-10-03) Health Canada named GHK-Cu in an advisory on unauthorized injectable peptide drugs seized from a business in Calgary, Alberta (page last updated 2025-04-02). (Health Canada advisory: unauthorized injectable peptide drugs seized in Calgary (2025), captured 2026-10-03) Health Canada named GHK-Cu in “GHK-Cu & BPC-157 powder: Unauthorized active pharmaceutical ingredients”. (Health Canada document, captured 2026-10-03) - Sport (WADA)WADA’s Prohibited List does not name GHK-Cu. WADA states that topical cosmetic products may contain prohibited peptides or growth factors and that using cosmetic products containing such substances is prohibited; we found no WADA statement on whether GHK-Cu is one of them. (WADA:
World Anti-Doping Code International Standard Prohibited List 2026
, captured 2026-10-03; WADA:The Prohibited List
, captured 2026-10-03)
Official sources: FDA: Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act
· FDA: Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks
· WADA: World Anti-Doping Code International Standard Prohibited List 2026
· WADA: The Prohibited List
· Health Canada: Think twice before injecting peptides bought online: unauthorized products can seriously harm you
· Health Canada advisory: unauthorized injectable peptide drugs seized (2025) · Health Canada advisory: unauthorized injectable peptide drugs seized in Calgary (2025) · Health Canada document
Report a side effect
If something went wrong after using a health product, tell a clinician. Report side effects to:
- FDA MedWatch (United States)
- Health Canada (report a side effect)
Common questions
Is GHK-Cu topical or injection?
Both are sold. On the skin, GHK-Cu is used in cosmetic anti-wrinkle products, and non-injectable GHK-Cu is in FDA's compounding Category 1. Injectable GHK-Cu is among the unauthorized peptides Health Canada has seized, and FDA says human data on injected GHK-Cu are limited.[2][7][9][3]
Is GHK-Cu safe to inject?
FDA says there are limited data in humans to inform its safety, and it flags possible immune reactions from aggregation and peptide-related impurities.[3]
Does GHK-Cu work topically?
Unproven. Cell and rat results are strong, but a 2025 review notes a surprising absence of clinical studies.[13][14][2]
Is GHK-Cu FDA approved?
We found no FDA-approved GHK-Cu product, in either form, in Drugs@FDA. Non-injectable GHK-Cu is in compounding Category 1, which is not an approval. FDA's safety page lists injectable GHK-Cu among substances whose Category 2 nominations were withdrawn.[3][7] Source: FDA: Drugs@FDA search: ghk-cu — no approved product found
Is GHK-Cu banned by WADA?
WADA's Prohibited List does not name GHK-Cu. WADA states that topical cosmetic products may contain prohibited peptides or growth factors and that using cosmetic products containing such substances is prohibited; we found no WADA statement on whether GHK-Cu is one of them.[17] Source: WADA: World Anti-Doping Code International Standard Prohibited List 2026
; WADA: The Prohibited List
References
References to papers were matched to their PubMed or DOI records. Regulator, label and registry pages were fetched and saved by us; each status line under Regulatory status gives the date its source was captured. "Verified" means the paper exists and is the one named; what it supports is stated next to each claim.
GHK-Cu as a Bioactive Metallopeptide and Drug-Delivery Cargo: Coordination Chemistry, Formulation Science, Therapeutic Evidence, and a Translational Roadmap.
PubMed 42797253 DOITopically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospective.
PubMed 39963574 DOICertain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks
SourceA Systematic Review of the Mechanisms and Therapeutic Applications of GHK-Cu (Glycyl-L-Histidyl-L-Lysine-Copper Complex) in Topical Microneedle Delivery: A Case for Expanded Clinical Trials.
PubMed 42787770 DOIAre We Ready to Measure Skin Permeation of Modern Antiaging GHK-Cu Tripeptide Encapsulated in Liposomes?
PubMed 39795193 DOIDrugs@FDA search: ghk-cu — no approved product found (2026-10-01)
SourceBulk Drug Substances Nominated for Use in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act
SourceHealth Canada Drug Product Database search: ghk-cu — no product found (2026-10-01)
SourceThink twice before injecting peptides bought online: unauthorized products can seriously harm you (Health Canada advisory; lists KPV)
SourceUnregulated Peptide Use in the Age of Biohacking: Digital Promotion, Gray-Market Access, and Emerging Public Health Risks.
PubMed 42437212 DOIDangers of Injectable Peptides and Other Unregulated "Biohacking" Drugs.
PubMed 42757290Human skin penetration of a copper tripeptide in vitro as a function of skin layer.
PubMed 20721598 DOIStimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+.
PubMed 3169264 DOIIn vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ in rat experimental wounds.
PubMed 8227353 DOISignificant improvement in crow's feet after treatment with Jet-M and a mixed solution of copper-GHK, oligo-hyaluronic acid, rhodiolar extract, tranexamic acid, and β-glucan (GHR formulation).
PubMed 27064823 DOIIs It a Cosmetic, a Drug, or Both? (Or Is It Soap?)
SourceThe Prohibited List
Source
Keep reading
- GHK-Cu before and after: what the trials actually measured→
- Best peptides for skin, ranked by evidence→
- GLOW peptide stack: components, evidence and risks→
- KLOW peptide: components, evidence and risks→
- Copper peptides vs retinol: what the evidence shows→
- Peptides for hair growth vs minoxidil and finasteride→
- All peptide pages, by evidence→